DK0689444T3 - Tylosinholdige veterinærpræparater med vedvarende afgivelse - Google Patents

Tylosinholdige veterinærpræparater med vedvarende afgivelse

Info

Publication number
DK0689444T3
DK0689444T3 DK94909996T DK94909996T DK0689444T3 DK 0689444 T3 DK0689444 T3 DK 0689444T3 DK 94909996 T DK94909996 T DK 94909996T DK 94909996 T DK94909996 T DK 94909996T DK 0689444 T3 DK0689444 T3 DK 0689444T3
Authority
DK
Denmark
Prior art keywords
sustained
sustained release
medicinal products
tylosin
veterinary medicinal
Prior art date
Application number
DK94909996T
Other languages
English (en)
Inventor
Alan Patterson
Drew Holmes
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Application granted granted Critical
Publication of DK0689444T3 publication Critical patent/DK0689444T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94909996T 1993-03-24 1994-03-22 Tylosinholdige veterinærpræparater med vedvarende afgivelse DK0689444T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition
PCT/GB1994/000578 WO1994021267A1 (en) 1993-03-24 1994-03-22 Tylosin containing sustained release veterinary compositions

Publications (1)

Publication Number Publication Date
DK0689444T3 true DK0689444T3 (da) 1999-11-22

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909996T DK0689444T3 (da) 1993-03-24 1994-03-22 Tylosinholdige veterinærpræparater med vedvarende afgivelse

Country Status (23)

Country Link
EP (1) EP0689444B1 (da)
JP (1) JPH08508032A (da)
KR (1) KR100283369B1 (da)
CN (1) CN1096268C (da)
AT (1) ATE181834T1 (da)
AU (1) AU669435B2 (da)
BG (1) BG62352B1 (da)
BR (1) BR9406202A (da)
CA (1) CA2158662C (da)
DE (1) DE69419408T2 (da)
DK (1) DK0689444T3 (da)
ES (1) ES2135568T3 (da)
FI (1) FI954447A (da)
GB (1) GB9306106D0 (da)
GR (1) GR3031293T3 (da)
HU (1) HUT73424A (da)
IL (1) IL109053A (da)
NO (1) NO953647L (da)
NZ (1) NZ262756A (da)
PE (1) PE7595A1 (da)
PL (1) PL175127B1 (da)
RO (1) RO114738B1 (da)
WO (1) WO1994021267A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
CN116407505A (zh) * 2023-03-28 2023-07-11 青岛康地恩动物药业有限公司 一种高生物利用度泰万菌素干混悬剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
ATE66600T1 (de) * 1986-03-10 1991-09-15 American Cyanamid Co Verfahren zur herstellung einer bolusformulierung mit verzoegerter freisetzung.

Also Published As

Publication number Publication date
IL109053A0 (en) 1994-06-24
HU9502700D0 (en) 1995-11-28
PL310804A1 (en) 1996-01-08
CN1096268C (zh) 2002-12-18
FI954447A (fi) 1995-11-15
BR9406202A (pt) 1995-12-12
WO1994021267A1 (en) 1994-09-29
EP0689444B1 (en) 1999-07-07
KR960700732A (ko) 1996-02-24
DE69419408D1 (de) 1999-08-12
GB9306106D0 (en) 1993-05-12
KR100283369B1 (ko) 2001-03-02
NO953647D0 (no) 1995-09-15
ATE181834T1 (de) 1999-07-15
PL175127B1 (pl) 1998-11-30
JPH08508032A (ja) 1996-08-27
CA2158662C (en) 2009-06-30
CN1123525A (zh) 1996-05-29
EP0689444A1 (en) 1996-01-03
FI954447A0 (fi) 1995-09-20
NO953647L (no) 1995-11-22
HUT73424A (en) 1996-07-29
GR3031293T3 (en) 1999-12-31
BG100078A (bg) 1996-07-31
AU669435B2 (en) 1996-06-06
BG62352B1 (bg) 1999-09-30
IL109053A (en) 1999-09-22
DE69419408T2 (de) 1999-10-28
PE7595A1 (es) 1995-04-25
AU6262194A (en) 1994-10-11
NZ262756A (en) 1997-06-24
RO114738B1 (ro) 1999-07-30
ES2135568T3 (es) 1999-11-01
CA2158662A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
DE69332222D1 (de) Enythropoietin enthaltendes arzneimittelabgabesystem
FI92014C (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
NZ512287A (en) Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
BRPI0416590A (pt) excipientes em veìculos de distribuição de fármacos
ES2186715T3 (es) Uso de un tensioactivo lipofilico en una composicion farmaceutica.
EP0671162A3 (en) Amphoteric compositions and polymer forms of alpha-hydroxy acids, and their therapeutic use.
EP1047399A4 (en) COMPOSITIONS FOR SKIN CARE
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
CA2063576A1 (en) Slow release vehicles for minimizing skin irritancy of topical compositions
PH31403A (en) Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
DK0689444T3 (da) Tylosinholdige veterinærpræparater med vedvarende afgivelse
ES2163147T3 (es) Perfeccionamientos de agentes antimicrobianos de accion prolongada o relativos a los mismos.
ES2039377T3 (es) Un supositorio.
ES8400028A1 (es) Metodo de preparacion de una composicion tixotropica anhidra.
NZ236474A (en) 4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof
WO2001049117A3 (en) An anti-viral lotion composition and a lotioned tissue product
JPS5750914A (en) Betamethasone external pharmaceutical
FR2622104B1 (fr) Procede de stabilisation de phases lamellaires lipidiques hydratees, par ex. de liposomes, composition de phases lamellaires lipidiques hydratees, par ex. des liposomes, stabilisees par un emploi d'un support stabilisant a base d'atelocollagene et de glycosaminoglycannes et utilisation en pharmacie ou en cosmetologie
TH18460EX (th) สารผสมทางสัตวแพทย์ ที่ปลดปล่อยแบบถูกหน่วงเหนี่ยวที่มีไทลอซิน
HUP9903088A2 (hu) Mupirocint és klórhexidint tartalmazó gyógyszerkészítmény
UA18708A (uk) Спосіб кислотhої обробки пласта
MY109207A (en) Subcutaneous implants based on nomegestrol derivatives
GR900100076A (en) Preparation method of novel pharmaceutical forms of cyclosporine